Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02045303 · ClinicalTrials.gov registry record · NA
Healing Rate of Leg Wounds Treated With Contact and Noncontact Ultrasound: The VIP Ultrasound Protocol
A NA study of Chronic Ulcer of Lower Extremity, sponsored by Texas Health Resources.
- Completed
- Registry status
- NA
- Development phase
- 11
- Enrollment target
- 1
- Study location
NCT02045303: Completed NA study of Chronic Ulcer of Lower Extremity, sponsored by Texas Health Resources.
NCT02045303 is a NA study of Chronic Ulcer of Lower Extremity that has completed, run by Texas Health Resources. The registered enrollment target is 11 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02045303, a NA study of Chronic Ulcer of Lower Extremity, has completed, sponsored by Texas Health Resources.
- COMPLETED
- Registry status
- NA
- Development phase
- 11 participants
- Enrollment target
- 1
- Study location
Study Summary
Wound healing rate is higher when contact ultrasound therapy is followed by noncontact ultrasound therapy on sub-acute and chronic lower extremity ulcers of various etiologies requiring selective debridement, as compared to either Sonoca-180 or MIST Therapy alone.
Primary Outcome
Mean and Standard Deviation of the group's total wound area at day one and last treatment day. Wound area was measured as Length x Width. This is to assess the change in area, in order to assess wound progress towards closure.
Conditions Studied
Interventions
- DEVICE Contact Ultrasound Therapy
- DEVICE Noncontact Ultrasound Therapy
Study Locations (1)
Texas
- Texas Health Resources - Presbyterian Hospital of Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2014-02 |
| Est. Completion | 2015-08 |
| Phase | NA |
What the finished NCT02045303 record still lists
NCT02045303 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 11 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Chronic Ulcer of Lower Extremity appearing as the primary indexed condition, and to 2 interventions - of which Contact Ultrasound Therapy is the first listed.
NCT02045303 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT02045303 about?
NCT02045303 is a clinical study titled "Healing Rate of Leg Wounds Treated With Contact and Noncontact Ultrasound: The VIP Ultrasound Protocol". Wound healing rate is higher when contact ultrasound therapy is followed by noncontact ultrasound therapy on sub-acute and chronic lower extremity ulcers of various etiologies requiring selective debridement, as compared to either Sonoca-180 or MIST Therapy alone.
What is the current status of trial NCT02045303?
This trial is currently completed. It is a NA study. The enrollment target is 11 participants. The study started on 2014-02. Estimated completion is 2015-08.
What conditions does trial NCT02045303 study?
This clinical trial studies the following conditions: Chronic Ulcer of Lower Extremity.
What interventions are being tested in trial NCT02045303?
The interventions under investigation include: Contact Ultrasound Therapy (DEVICE), Noncontact Ultrasound Therapy (DEVICE).
Who is sponsoring clinical trial NCT02045303?
This trial is sponsored by Texas Health Resources, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02045303 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Chronic Ulcer of Lower Extremity
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02045303's enrollment target sits among peer trials
11 1927th of 2000 higher than 74 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03114462 · 11 participants · Phase 1
Trial of Stereotactic HYpofractionateD RadioAblative (HYDRA) Treatment of Laryngeal Cancer
- NCT06039709 · 11 participants · Phase 1
Sonodynamic Therapy in Patients With Recurrent GBM
- NCT06425380 · 11 participants · NA
Pilot Open-Label Trial of Resistant Potato Starch in Patients With Cirrhosis and Overt Hepatic Encephalopathy
- NCT06472661 · 11 participants · Early Phase 1
FUSA With Intratumoral PolyICLC in Regionally Advanced Resectable Melanoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia